日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Camrelizumab Plus Nab-paclitaxel in Patients with Previously Treated Advanced Urothelial Carcinoma: A Multicenter Phase II Study

卡瑞利珠单抗联合白蛋白紫杉醇治疗既往接受过治疗的晚期尿路上皮癌患者：一项多中心 II 期研究

期刊:Cancer Communications
影响因子:24.9
doi:10.34133/cancomm.0025
Li, Haifeng; Chen, Meiting; Huang, Riqing; Rong, Qixiang; Hao, Jing; Zheng, Qiufan; Su, Yanhong; Shu, Ditian; Zhang, Yue; Yang, Wei; Lei, Xuefen; Cai, Yuchen; Xue, Cong; An, Xin; Shi, Yanxia
肿瘤
肿瘤免疫
发表日期：2026
文献求助 收藏

Identification of Paraptosis-Related Renal Cell Carcinoma Subtypes, Construction of a Prognostic Signature, and Determination of Tumor Microenvironment Landscape Using Bioinformatic Analysis and Experimental Verification.

利用生物信息学分析和实验验证鉴定副凋亡相关肾细胞癌亚型、构建预后特征并确定肿瘤微环境图谱。

期刊:Current Issues in Molecular Biology
影响因子:3
doi:10.3390/cimb48020233
Qin Mengyuan, Chen Meiting, Gan Yuling, Feng Xiangqian, Huang Ping, Meng Feifei, Yang Yufang
肿瘤
凋亡
表观遗传
肿瘤免疫
肾癌
细胞生物学
肿瘤微环境
发表日期：2026
文献求助 收藏

PD-1/PD-L1 Inhibitors Plus Chemotherapy Versus Chemotherapy Alone as First-Line Therapy for Patients With Unfavorable Cancer of Unknown Primary: A Multicenter, Retrospective Cohort Study

PD-1/PD-L1抑制剂联合化疗与单纯化疗作为一线治疗原发灶不明且预后不良的癌症患者的疗效比较：一项多中心回顾性队列研究

期刊:MedComm
影响因子:10.7
doi:10.1002/mco2.70124
Huang, Riqing; Li, Haifeng; Li, Shuo; Shu, Ditian; Chen, Rishang; Zheng, Zhousan; Gao, Tinghua; Chen, Meiting; Hu, Anqi; Huang, Yunjie; Zheng, Qiufan; An, Xin; Xue, Cong; Cai, Yuchen; Shi, Yanxia
PD-L1
肿瘤
PD-1
肿瘤免疫
发表日期：2025
文献求助 收藏

Bevacizumab, tislelizumab and nab-paclitaxel for previously untreated metastatic triple-negative breast cancer: a phase II trial

贝伐珠单抗、替雷利珠单抗和白蛋白紫杉醇联合治疗既往未接受治疗的转移性三阴性乳腺癌：一项 II 期试验

期刊:Journal for ImmunoTherapy of Cancer
影响因子:10.6
doi:10.1136/jitc-2024-011314
Chen, Meiting; Huang, Riqing; Rong, Qixiang; Yang, Wei; Shen, Xiujiao; Sun, Qi; Shu, Ditian; Jiang, Kuikui; Xue, Cong; Peng, Jing; An, Xin; Li, Haifeng; Xu, Fei; Shi, Yanxia
肿瘤
肿瘤免疫
乳腺癌
发表日期：2025
文献求助 收藏

Osteosclerotic changes on computed tomography predict disease progression and poor survival in prostate cancer with osteoblastic metastases

计算机断层扫描显示的骨硬化改变可预测伴有成骨性转移的前列腺癌的疾病进展和不良生存期

期刊:International Journal of Surgery
影响因子:10.1
doi:10.1097/JS9.0000000000002758
Chen, Meiting; Yang, Zhenhua; Yang, Shuai; Wang, Jun; Xie, YuPing; Huang, Riqing; Li, Haifeng; Li, Yonghong; Shi, Yanxia; Li, Sheng
肿瘤
前列腺癌
肿瘤免疫
发表日期：2025
文献求助 收藏

Impacts of genomic alterations on the efficacy of HER2-targeted antibody-drug conjugates in patients with metastatic breast cancer

基因组改变对转移性乳腺癌患者HER2靶向抗体药物偶联物疗效的影响

期刊:Journal of Translational Medicine
影响因子:7.5
doi:10.1186/s12967-025-06082-5
Huang, Riqing; Hu, Anqi; Rong, Qixiang; Shu, Ditian; Chen, Meiting; Yang, Wei; Zhang, Yue; Zheng, Qiufan; An, Xin; Xue, Cong; Li, Haifeng; Shi, Yanxia
HER2
肿瘤
肿瘤免疫
乳腺癌
发表日期：2025
文献求助 收藏

Efficacy and safety of modified bleomycin administration with EP chemotherapy in adult male patients with germ cell tumors: a retrospective study

改良博来霉素联合EP方案化疗治疗成年男性生殖细胞肿瘤患者的疗效和安全性：一项回顾性研究

期刊:Cancer Cell International
影响因子:6
doi:10.1186/s12935-025-03774-2
Shu, Ditian; Huang, Riqing; Chen, Meiting; Li, Haifeng; An, Xin; Xue, Cong; Hu, Anqi; Zhou, Fangjian; Yao, Kai; Liu, Zhuowei; Shi, Yanxia
细胞生物学
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Construction of a novel gene signature linked to ferroptosis in pediatric sepsis

构建与儿童脓毒症铁死亡相关的新型基因特征

期刊:Frontiers in Cell and Developmental Biology
影响因子:4.3
doi:10.3389/fcell.2025.1488904
Fan, Mingyuan; Chen, Meiting; Gao, Yongqi; Jiang, Huilin; Li, Yanling; Zhu, Gongxu; Chen, Shengkuan; Xu, Yiming; Chen, Xiaohui
炎症/感染
败血症
铁死亡
发表日期：2025
文献求助 收藏

Prognostic index for predicting outcomes of trastuzumab deruxtecan in HER2 expressing metastatic breast cancer: a real-world multicenter study

预测曲妥珠单抗德鲁替康治疗HER2阳性转移性乳腺癌疗效的预后指数：一项真实世界多中心研究

期刊:Oncologist
影响因子:4.2
doi:10.1093/oncolo/oyaf174
Xue, Cong; Liao, Qianyi; Huang, Riqing; Huang, Yunjie; Chen, Rishang; Yang, Zhenhua; Shen, Xiujiao; Li, Haifeng; Rong, Qixiang; Shu, Ditian; Pan, Fei; Shi, Yanxia; Chen, Meiting
HER2
肿瘤
肿瘤免疫
乳腺癌
发表日期：2025
文献求助 收藏

Estradiol levels in women with hormone receptor-positive advanced breast cancer on fulvestrant therapy

接受氟维司群治疗的激素受体阳性晚期乳腺癌女性的雌二醇水平

期刊:Oncologist
影响因子:4.2
doi:10.1093/oncolo/oyaf403
Dai, Shuqin; Wen, Yanling; Wu, Xingping; Wang, Xi; Yuan, Zhongyu; Xu, Fei; Xie, Xiaoming; Xia, Wen; Wang, Shusen; Shi, Yanxia; Liu, Peng; Zheng, Qiufan; Tang, Jun; An, Xin; Huang, Jiajia; Chen, Meiting; Zhong, Yongyi; Bi, Xiwen; Yang, Yi; Xue, Cong
肿瘤
肿瘤免疫
信号转导
乳腺癌
免疫/内分泌
发表日期：2025
文献求助 收藏